Opinion

Video

Venetoclax-Based Treatment Clinical Trial Updates

Author(s):

Yuliya P.L Linhares, MD,Josie Montegaard, MSN, AGPCNP-BC

Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
      Investigating Quality of Life and Treatment Adherence in Kidney Cancer
      .Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
      Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
      Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
      Personalized Kidney Cancer Vaccine May Help Prevent Future Relapse
      Image of man with brown hair.
      ‘The Future Is Bright’ for R/R CLL Treatment Landscape
      Image of a man wearing a black button-up shirt.
      Understanding Treatment Sequences in Managing R/R CLL
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      Related Content
      There were a number of notable developments for patients with kidney cancer at the symposium: © SciePro - stock.adobe.com
      March 30th 2025

      What Patients With Kidney Cancer Need to Know From ASCO GU

      Alex Biese
      There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.
      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
      January 22nd 2024

      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

      Alex Biese Brielle Benyon
      We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
      Chester Freeman was diagnosed with bladder cancer and most recently with chronic lymphocytic leukemia (CLL). Read Chester's blogs here!
      March 25th 2025

      Navigating a Diagnosis of Diabetes and Chronic Lymphocytic Leukemia

      Chester Freeman
      Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.
      CURE Talks Cancer podcast
      December 31st 2020

      The Treatment Journey of a Patient with CLL

      Kristie L. Kahl
      In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
      Image of chester.
      March 12th 2025

      Four Things to Remember When Both Spouses Have Cancer

      Chester Freeman
      When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and managing stress helped us through it.
      Illustration of blood cells.
      March 7th 2025

      Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia

      Spencer Feldman
      Calquence plus Venclexta with or without Gazyva significantly improved progression-free survival in patients with untreated CLL.